OR WAIT null SECS
Grant Playter is Associate Editor for Pharmaceutical Technology, BioPharm International, and Pharmaceutical Technology Europe.
May 30, 2023
Aragen and FAR Biotech will collaborate to advance a small-molecule neurodegeneration program.
The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.
The guidance describes FDA’s current recommendations regarding adjusting for covariates in statistical analysis of randomized clinical trials.
The next Cannabis Science Conference Fall meeting is soliciting a call for abstracts.
May 26, 2023
Myrna Wilson, director, Global Marketing, Strategic Growth and Technical Sales, Pharmaceutical Ingredients, Univar Solutions, discusses the state of the biopharma supply chain, movements in the patent industry, and more.
May 25, 2023
Andrea Lodetti, CEO of Bormioli Pharma, an Italian pharma primary packaging manufacturer, speaks about his company's approach to the US market, supply chain instabilities, sustainability, and more.